PTEN and cancer: PTEN is an “obligate haploinsufficient” tumor suppressor gene that functions in a dose-dependent manner, and even a subtle reduction in PTEN level or activity could enhance cancer susceptibility [27], which offers therapeutic opportunities for reactivation of tumor suppressor in cancer treatment.